SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-198630
Filing Date
2005-10-11
Accepted
2005-10-07 20:03:48
Documents
4
Period of Report
2005-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 18641
2 SEPARATION AGREEMENT AND RELEASE dex101.htm EX-10.1 23252
3 ACQUISITION BONUS AND SEVERANCE AGREEMENT dex102.htm EX-10.2 41441
4 ACQUISITION BONUS AGREEMENT dex103.htm EX-10.3 23734
  Complete submission text file 0001193125-05-198630.txt   108472
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 051130537
SIC: 2834 Pharmaceutical Preparations